Top Abstract Purchase Preview Related
Home
>
Node
>
Subnode

Psychopharmacological approach with the usage of selective serotonin reuptake inhibitors in functional dyspepsia treatment

Korendovych, I.V.; Svintsits'kyĭ, A.S.; Revenok, K.M.; Maliarov, S.O.

Likars'ka Sprava 11: 58-64

2014

ISSN/ISBN: 1019-5297
PMID: 25528834
Document Number: 16806
Objective: To assess the efficacy of selective serotonin reuptake inhibitor (SSRI) escitalopram in patients with functional dyspepsia (FD). Treatment results showed reduction of dyspeptic symptoms as well as significant decrease of anxiety and depression and improvement of quality of life in patients, who were additionally prescribed SSRI.

Document emailed within 1 workday
Secure & encrypted payments

Psychopharmacological approach with the usage of selective serotonin reuptake inhibitors in functional dyspepsia treatment

Posternak, M.A.; Zimmerman, M. 2005: Dual reuptake inhibitors incur lower rates of tachyphylaxis than selective serotonin reuptake inhibitors: a retrospective study Journal of Clinical Psychiatry 66(6): 705-707
Nurnberg, H.G.; Thompson, P.M.; Hensley, P.L. 1999: Antidepressant medication change in a clinical treatment setting: a comparison of the effectiveness of selective serotonin reuptake inhibitors Journal of Clinical Psychiatry 60(9): 574-579
DeVane, C.L. 1992: Pharmacokinetics of the selective serotonin reuptake inhibitors Journal of Clinical Psychiatry 53 Suppl: 13-20
Mayer, L.E.; Walsh, B.T. 1998: The use of selective serotonin reuptake inhibitors in eating disorders Journal of Clinical Psychiatry 59(Suppl): 28-34
Dudek, D.; Zieba, A.; Siwek, M.; Wróbel, A. 2004: Selective serotonin reuptake inhibitors--current knowledge Psychiatria Polska 38(3): 507-524
Mahendran, R. 2006: The risk of suicidality with selective serotonin reuptake inhibitors Annals of the Academy of Medicine Singapore 35(2): 96-99
Marangell, L.B.; Johnson, C.R.; Kertz, B.; Zboyan, H.A.; Martinez, J.M. 2002: Olanzapine in the treatment of apathy in previously depressed participants maintained with selective serotonin reuptake inhibitors: an open-label, flexible-dose study Journal of Clinical Psychiatry 63(5): 391-395
Nakielny, J.; Eckett, S. 1994: Selective serotonin reuptake inhibitors. Calculation of costs is incorrect Bmj 309(6961): 1082-3; Author Reply 1085
Condat, A.; Mouren-Simeoni, M.C. 2000: Selective serotonin reuptake inhibitors and depression in the child and adolescent L'Encephale 26(3): 53-60
Ostroff, R.B.; Nelson, J.C. 1999: Risperidone augmentation of selective serotonin reuptake inhibitors in major depression Journal of Clinical Psychiatry 60(4): 256-259
Tracey, D. 1994: Selective serotonin reuptake inhibitors. Commercial interests should not influence prescribing Bmj 309(6961): 1083-4; Author Reply 1085
Nelson, S.A.; Wilson, G.A.; Tucci, M.; Benghuzzi, H. 2015: The Effect of Selective Serotonin Reuptake Inhibitors and Antidiabetic Drugs on Cardiomyocytes Biomedical Sciences Instrumentation 51: 400-406
Fonzo-Christe, C.; Vogt, N. 2000: Susceptibility of the elderly patient to hyponatremia induced by selective serotonin reuptake inhibitors Therapie 55(5): 597-604
Van Ermen, A.M.; Ottervanger, J.P.; Roisin, T.; Kurz, X.; Stricker, B.H. 1996: Reports of suspected side effects of selective serotonin reuptake inhibitors in Belgium and The Netherlands Nederlands Tijdschrift Voor Geneeskunde 140(36): 1817-1820
Wan, G.J.; Crown, W.H.; Berndt, E.R.; Finkelstein, S.N.; Ling, D. 2002: Healthcare expenditure in patients treated with venlafaxine or selective serotonin reuptake inhibitors for depression and anxiety International Journal of Clinical Practice 56(6): 434-439
Kulin, N.A.; Pastuszak, A.; Sage, S.R.; Schick-Boschetto, B.; Spivey, G.; Feldkamp, M.; Ormond, K.; Matsui, D.; Stein-Schechman, A.K.; Cook, L.; Brochu, J.; Rieder, M.; Koren, G. 1998: Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study JAMA 279(8): 609-610
Yamauchi, M.; Hiraoka, S.; Imanishi, T. 2006: Role of the serotonergic nervous system in anxiety disorders and the anxiolytic mechanism of selective serotonin reuptake inhibitors Nihon Shinkei Seishin Yakurigaku Zasshi 26(5-6): 193-198
Pedrós, C.; Cereza, G.; Garcia, Núria. 2004: Hyponatremia and syndrome of inappropriate secretion of antidiuretic hormone induced by selective serotonin reuptake inhibitors: review of spontaneous reports Medicina Clinica 123(13): 516-517
Eriksson, E. 1999: Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria International Clinical Psychopharmacology 14(Suppl 2): S27-S33
Zajecka, J.; Tracy, K.A.; Mitchell, S. 1997: Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review Journal of Clinical Psychiatry 58(7): 291-297